EM2AI, a 49%-owned associate of Mainboard-listed Q&M Dental, has entered into a memorandum of understanding (MOU) with a dental solutions provider to deploy its artificial intelligence (AI) solutions in over 1,000 dental clinics across the region.
This announcement follows EM2AI’s recent success in securing medical device licenses in four ASEAN markets—Thailand, Vietnam, Indonesia, and the Philippines, as reported on January 13.
Currently, EM2AI’s AI solutions are available in Singapore and Malaysia. Founded in 2018 and headquartered in Singapore, the company has developed advanced healthcare software designed to enhance diagnostic accuracy in dentistry, offering what it describes as a “second opinion” for practitioners. Notable solutions from EM2AI include an AI-powered cloud platform focused on patient care and an AI system for detecting dental conditions via x-rays, as well as automating dental charting.
Q&M Dental reduced its equity stake in EM2AI from 100% to 49% in March 2024, selling off 51% of the company. The MOU is set to remain valid for six months, during which both parties will negotiate the terms of a formal agreement. If finalized, EM2AI will expand its AI solutions to more than 1,000 clinics in Singapore, Malaysia, Thailand, and Vietnam.
At 9:41 AM, Q&M Dental shares were up 0.5 cents, or 1.82%, trading at 28 cents.
Related topics:
Expert Tips to Prevent Teeth Staining and Keep Your Smile Bright
Patrick Mahomes Joins Invisalign Smile Squad as Brand Ambassador
DrDent Professional Teeth Whitening Strips Offer Budget-Friendly, Dentist-Approved Results
